Prognostic Utility of Pretreatment Neutrophil-Lymphocyte Ratio in Advanced Larynx Cancer

1. Fitzmaurice, C, Abate, D, Abbasi, N, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5:1749-1768.
Google Scholar | Crossref | Medline2. Cattaruzza, MS, Maisonneuve, P, Boyle, P. Epidemiology of laryngeal cancer. Eur J Cancer B Oral Oncol. 1996;32:293-305.
Google Scholar | Crossref3. Zhang, SY, Lu, ZM, Luo, XN, et al. Retrospective analysis of prognostic factors in 205 patients with laryngeal squamous cell carcinoma who underwent surgical treatment. PLoS One. 2013;8:e60157.
Google Scholar4. Forastiere, AA, Ismaila, N, Lewin, JS, et al. Use of larynx-preservation strategies in the treatment of laryngeal cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol. 2018;36:1143-1169.
Google Scholar | Crossref | Medline5. Hanahan, D, Weinberg, RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646-674.
Google Scholar | Crossref | Medline | ISI6. Tezal, M, Scannapieco, FA, Wactawski-Wende, J, et al. Local inflammation and human papillomavirus status of head and neck cancers. Arch Otolaryngol Head Neck Surg. 2012;138:669-675.
Google Scholar | Crossref | Medline7. Coussens, LM, Werb, Z. Inflammation and cancer. Nature. 2002;420:860-867.
Google Scholar | Crossref | Medline | ISI8. Gao, X, Coull, B, Lin, X, et al. Association of neutrophil to lymphocyte ratio with pulmonary function in a 30-year longitudinal study of US veterans. JAMA Netw open. 2020;3:e2010350.
Google Scholar | Crossref9. Shah, N, Parikh, V, Patel, N, et al. Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: insights from the National Health and Nutrition Examination Survey-III. Int J Cardiol. 2014;171:390-397.
Google Scholar | Crossref | Medline | ISI10. Templeton, AJ, McNamara, MG, Šeruga, B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106:dju124.
Google Scholar | Crossref11. Tu, XP, Tian, T, Chen, L-S, et al. Prognostic values of preoperative NLR and PLR in patients with laryngeal squamous cell carcinoma. Transl Cancer Res. 2018;7:301-309.
Google Scholar | Crossref12. American College of Surgeons Commission on Cancer . FORDS Facility Oncology Registry Data Standards Revised for 2016. 2016. https://www.facs.org/-/media/files/quality-programs/cancer/ncdb/fords-2016.ashx
Google Scholar13. Zullig, LL, Jackson, GL, Dorn, RA, et al. Cancer incidence among patients of the U.S. Veterans Affairs Health Care System. Mil Med. 2012;177:693-701.
Google Scholar | Crossref | Medline | ISI14. Quan, H, Sundararajan, V, Halfon, P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130-1139.
Google Scholar | Crossref | Medline | ISI15. Klabunde, CN, Potosky, AL, Legler, JM, Warren, JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53:1258-1267.
Google Scholar | Crossref | Medline | ISI16. Williams, BA, Mandrekar, JN, Mandrekar, SJ, et al. Finding optimal cutpoints for continuous covariates with binary and time-to-event outcomes. 2006. https://www.mayo.edu/research/documents/biostat-79pdf/doc-10027230
Google Scholar17. Kamarudin, AN, Cox, T, Kolamunnage-Dona, R. Time-dependent ROC curve analysis in medical research: current methods and applications. BMC Med Res Methodol. 2017;17:53.
Google Scholar | Crossref | Medline18. Contal, C, O’Quigley, J. An application of changepoint methods in studying the effect of age on survival in breast cancer. Comput Stat Data Anal. 1999;30:253-270.
Google Scholar | Crossref19. Meyers, JP, Mandrekar, JN. Cutpoint determination methods in survival analysis using SAS®: Updated %FINDCUT macro. https://support.sas.com/resources/papers/proceedings15/3249-2015.pdf
Google Scholar20. Zeng, YC, Chi, F, Xing, R, et al. Pre-treatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy. Jpn J Clin Oncol. 2016;46:126-131.
Google Scholar | Medline21. Fu, Y, Liu, W, OuYang, D, Yang, A, Zhang, Q. Preoperative neutrophil-to-lymphocyte ratio predicts long-term survival in patients undergoing total laryngectomy with advanced laryngeal squamous cell carcinoma: a single-center retrospective study. Medicine. 2016;95:e2689.
Google Scholar | Crossref22. Du, J, Liu, J, Zhang, X, et al. Pre-treatment neutrophil-to-lymphocyte ratio predicts survival in patients with laryngeal cancer. Oncol Lett. 2018;15:1664-1672.
Google Scholar | Medline23. Wu, Y, Zhao, Q, Peng, C, Sun, L, Li, XF, Kuang, DM. Neutrophils promote motility of cancer cells via a hyaluronan-mediated TLR4/PI3K activation loop. J Pathol. 2011;225:438-447.
Google Scholar | Crossref | Medline24. Gooden, MJ, de Bock, GH, Leffers, N, Daemen, T, Nijman, HW. The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer. 2011;105:93-103.
Google Scholar | Crossref | Medline | ISI25. Rakoff-Nahoum, S . Why cancer and inflammation? Yale J Biol Med. 2006;79:123-130.
Google Scholar | Medline26. Brigati, C, Noonan, DM, Albini, A, Benelli, R. Tumors and inflammatory infiltrates: friends or foes? Clin Exp Metastasis. 2002;19:247-258.
Google Scholar | Crossref | Medline27. Kum, RO, Ozcan, M, Baklaci, D, et al. Elevated neutrophil-to-lymphocyte ratio in squamous cell carcinoma of larynx compared to benign and precancerous laryngeal lesions. Asian Pac J Cancer Prev. 2014;15:7351-7355.
Google Scholar | Crossref | Medline28. Duzlu, M, Karamert, R, Tutar, H, Karaloglu, F, Sahin, M, Cevizci, R. Neutrophil-lymphocyte ratio findings and larynx carcinoma: a preliminary study in Turkey. Asian Pac J Cancer Prev. 2015;16:351-354.
Google Scholar | Crossref | Medline29. Kuo, C, Hsueh, WT, Wu, YH, et al. The role of pretreatment serum neutrophil-to-lymphocyte ratio in hypopharyngeal cancer treated with definitive chemoradiotherapy: a pilot study. Sci Rep. 2019;9:1618.
Google Scholar | Crossref | Medline30. Cho, Y, Kim, JW, Yoon, HI, Lee, CG, Keum, KC, Lee, IJ. The prognostic significance of neutrophil-to-lymphocyte ratio in head and neck cancer patients treated with radiotherapy. J Clin Med. 2018;7:512.
Google Scholar | Crossref31. Howard, R, Kanetsky, PA, Egan, KM. Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer. Sci Rep. 2019;9:19673.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif